A New Pathway With BronchOscopic or Oesophageal Ultrasound for Lung Cancer Diagnosis and STaging (BOOST) — BOOST  

Bronchogenic Carcinoma Clinical Trial

Official title: A Randomized Controlled Trial of Endobronchial or Endoscopic Ultrasound as a First Test in the Diagnosis and Staging of Lung Cancer

Status Completed

Clinical Trial Summary

In the UK, staging of lung cancer is time consuming (taking on average more than 3 weeks), costly and inaccurate in up to 20% of cases. The investigators wish to determine whether using the newer techniques of endobronchial ultrasound (EBUS) and endoscopic ultrasound (EUS) improves lung cancer staging. The investigators' hypothesis is that EUS (endoscopic ultrasound) or EBUS (endobronchial ultrasound guided transbronchial needle aspirate) as a first test after CT scan in the diagnosis and staging of lung cancer will result in a reduction in the time from first outpatient appointment to treatment decision, a reduction in the total number of scans and investigative operations, fewer outpatient attendances and a reduction in healthcare costs.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Bronchogenic Carcinoma
• Carcinoma, Bronchogenic

• NCT number: NCT00652769
• Study type: Interventional
• Source: University College London Hospitals
• Status: Completed
• Phase: Phase 3
• Start date: March 2008
• Completion date: July 2012